MediPal Holdings Corporation

7459.T · JPX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Revenue¥952,403¥945,159¥864,156¥982,500
% Growth0.8%9.4%-12%
Cost of Goods Sold¥890,171¥880,481¥806,025¥914,716
Gross Profit¥62,232¥64,678¥58,131¥67,784
% Margin6.5%6.8%6.7%6.9%
R&D Expenses¥0¥0¥0¥0
G&A Expenses¥0¥41,075¥42,151¥40,206
SG&A Expenses¥51,203¥47,267¥47,893¥46,194
Sales & Mktg Exp.¥0¥6,192¥5,747¥5,988
Other Operating Expenses¥0¥3,358¥0¥3,380
Operating Expenses¥51,203¥50,625¥47,893¥49,574
Operating Income¥11,029¥14,053¥10,238¥18,210
% Margin1.2%1.5%1.2%1.9%
Other Income/Exp. Net¥10,114¥4,612¥553¥7,958
Pre-Tax Income¥21,143¥18,665¥10,791¥26,168
Tax Expense¥6,271¥6,054¥4,488¥8,510
Net Income¥12,504¥9,586¥4,042¥14,511
% Margin1.3%1%0.5%1.5%
EPS60.6346.1719.4369.78
% Growth31.3%137.6%-72.2%
EPS Diluted60.6346.1719.4369.78
Weighted Avg Shares Out206208208208
Weighted Avg Shares Out Dil206208208208
Supplemental Information
Interest Income¥88¥0¥35¥3
Interest Expense¥3¥3¥2¥2
Depreciation & Amortization¥4,620¥3,353¥4,646¥4,625
EBITDA¥25,769¥17,411¥15,442¥30,797
% Margin2.7%1.8%1.8%3.1%
MediPal Holdings Corporation (7459.T) Financial Statements & Key Stats | AlphaPilot